James P Utz, MD in Rochester, MN - Medicare Pulmonary Disease

James P Utz, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Rochester, Minnesota. He went to Mayo Medical School and graduated in 1985 and has 39 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Mayo Clinic and his current practice location is 200 1st St Sw, Rochester, Minnesota. You can reach out to his office (for appointments etc.) via phone at (507) 284-2511.

James P Utz is licensed to practice in Minnesota (license number 30196) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1962480681.

Contact Information

	James P Utz, MD
	200 1st St Sw, Rochester, MN 55905-0001
	(507) 284-2511
	Not Available

Physician's Profile

Full Name	James P Utz
Gender	Male
Speciality	Pulmonary Disease
Experience	39 Years
Location	200 1st St Sw, Rochester, Minnesota
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

James P Utz attended and graduated from Mayo Medical School in 1985

NPI Data:

NPI Number: 1962480681
Provider Enumeration Date: 01/03/2006
Last Update Date: 08/21/2020

Medicare PECOS Information:

PECOS PAC ID: 9739224585
Enrollment ID: I20100303001155

Medical Identifiers

Medical identifiers for James P Utz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962480681	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	30196 (Minnesota)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Mayo Clinic Hospital Rochester	Rochester, MN	Hospital
Mayo Clinic Health System - Albert Lea And Austin	Albert lea, MN	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Mayo Clinic	6507778255	4232

News Archive

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.

Rosiglitazone therapy associated with increased risk for heart attack: Study

Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Cancer cells that fuse with macrophages play key role in the spread of cancer

Cancer cells that spontaneously fuse with macrophages, the immune system's healthy scavenger cells, play a key role in the metastasis, or spread of the cancer to other areas of the body, according to research to be presented Sunday, Dec. 15, at the American Society for Cell Biology annual meeting in New Orleans.

Researchers identify mechanism with which cancer cells protect themselves against damage

Although many cancer drugs have already been in use for decades, their mode of action is still unknown. The new research results now challenge a mechanism of action that was previously proposed for a group of drugs and supported with experiments: the Topoisomerase I-inhibitor Camptothecin (Top1 inhibitor for short) and its derivatives used in chemotherapy, Topotecan and Irinotecan.

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Republicans should go to the White House and say they are willing to see top tax rates go up to 36 percent or 37 percent and they are willing to forgo a debt-ceiling fight for this year.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James P Utz allows following entities to bill medicare on his behalf.

Entity Name	Mayo Clinic
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285

News Archive

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.

Rosiglitazone therapy associated with increased risk for heart attack: Study

Cancer cells that fuse with macrophages play key role in the spread of cancer

Researchers identify mechanism with which cancer cells protect themselves against damage

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Republicans should go to the White House and say they are willing to see top tax rates go up to 36 percent or 37 percent and they are willing to forgo a debt-ceiling fight for this year.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James P Utz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James P Utz, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511	James P Utz, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511

News Archive

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.

Rosiglitazone therapy associated with increased risk for heart attack: Study

Cancer cells that fuse with macrophages play key role in the spread of cancer

Researchers identify mechanism with which cancer cells protect themselves against damage

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Republicans should go to the White House and say they are willing to see top tax rates go up to 36 percent or 37 percent and they are willing to forgo a debt-ceiling fight for this year.

Internal Medicine Doctors in Rochester, MN

Emily Leasure, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Jorge A Velosa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Michael Ruediger Mueller, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Mr. Karun Singh Badwal, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Michal Reid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Katherine Desprez Wick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511
Dr. Allison Bock, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511

James P Utz, MD - Medicare Pulmonary Disease in Rochester, MN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

Rosiglitazone therapy associated with increased risk for heart attack: Study

Cancer cells that fuse with macrophages play key role in the spread of cancer

Researchers identify mechanism with which cancer cells protect themselves against damage

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Medicare Reassignments

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

Rosiglitazone therapy associated with increased risk for heart attack: Study

Cancer cells that fuse with macrophages play key role in the spread of cancer

Researchers identify mechanism with which cancer cells protect themselves against damage

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA approves Cuvposa Oral Solution for chronic severe drooling in children

Rosiglitazone therapy associated with increased risk for heart attack: Study

Cancer cells that fuse with macrophages play key role in the spread of cancer

Researchers identify mechanism with which cancer cells protect themselves against damage

Viewpoints: David Brooks' formula to avoid Cliff; Krugman says control costs, don't cut coverage

Internal Medicine Doctors in Rochester, MN